A survey of the burden of allergic rhinitis in Europe.

PubWeight™: 1.71‹?› | Rank: Top 3%

🔗 View Article (PMID 17927674)

Published in Allergy on January 01, 2007

Authors

G W Canonica1, J Bousquet, J Mullol, G K Scadding, J C Virchow

Author Affiliations

1: Facoltà di Medicina e Chirurgia, Dipartimento di Medicina Interna e Specialità Mediche (DIMI), University of Genova, Genova, Italy.

Articles citing this

Allergic Rhinitis and Its Impact on Asthma in Asia Pacific and the ARIA Update 2008. World Allergy Organ J (2012) 1.19

Treatment of allergic rhinitis and urticaria: a review of the newest antihistamine drug bilastine. Ther Clin Risk Manag (2016) 0.97

Burden of illness and quality of life in patients being treated for seasonal allergic rhinitis: a cohort survey. Clin Transl Allergy (2013) 0.96

The hidden burden of adult allergic rhinitis: UK healthcare resource utilisation survey. Clin Transl Allergy (2015) 0.95

Assessment of disease control in allergic rhinitis. Clin Transl Allergy (2013) 0.95

Allergen immunotherapy and allergic rhinitis: false beliefs. BMC Med (2013) 0.92

The burden of rhinitis and rhinoconjunctivitis in adolescents. Allergy Asthma Immunol Res (2014) 0.91

The status quo and unmet needs in the management of allergic rhinitis and chronic rhinosinusitis: a Malaysian perspective. Asia Pac Allergy (2014) 0.87

Allergic rhinitis and its impact on work productivity in primary care practice and a comparison with other common diseases: the Cross-sectional study to evAluate work Productivity in allergic Rhinitis compared with other common dIseases (CAPRI) study. Am J Rhinol Allergy (2012) 0.86

Skin prick test reactivity to common aeroallergens and ARIA classification of allergic rhinitis in patients of Central Greece. Eur Arch Otorhinolaryngol (2010) 0.83

Determinants for a low health-related quality of life in asthmatics. Ups J Med Sci (2011) 0.82

Hay fever in a changing climate: linking an Internet-based diary with environmental data. Ecohealth (2012) 0.81

Prevalence and risk factors for allergic rhinitis in two resource-limited settings in Peru with disparate degrees of urbanization. Clin Exp Allergy (2015) 0.80

The current role of sublingual immunotherapy in the treatment of allergic rhinitis in adults and children. J Asthma Allergy (2011) 0.79

A randomized DBPC trial to determine the optimal effective and safe dose of a SLIT-birch pollen extract for the treatment of allergic rhinitis: results of a phase II study. Allergy (2015) 0.79

A survey of the burden of allergic rhinitis in Hungary from a specialist's perspective. Multidiscip Respir Med (2012) 0.78

"The value of pre- and co-seasonal sublingual immunotherapy in pollen-induced allergic rhinoconjunctivitis". Clin Transl Allergy (2015) 0.78

Efficacy and Safety of Sanfu Herbal Patch at Acupoints for Persistent Allergic Rhinitis: Study Protocol for a Randomized Controlled Trial. Evid Based Complement Alternat Med (2015) 0.77

Burden of allergic respiratory disease: a systematic review. Clin Mol Allergy (2016) 0.77

Interactions of physical, chemical, and biological weather calling for an integrated approach to assessment, forecasting, and communication of air quality. Ambio (2012) 0.77

ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle. Clin Transl Allergy (2016) 0.77

[Allergic rhinitis and its impact on asthma (ARIA update 2008). The Austrian perspective]. Wien Med Wochenschr (2009) 0.76

A Systematic and Narrative Review of Acupuncture Point Application Therapies in the Treatment of Allergic Rhinitis and Asthma during Dog Days. Evid Based Complement Alternat Med (2015) 0.76

Alleviation and prevention of severe allergic rhinitis and conjunctivitis following long-term lemon juice use: a case report. Cases J (2009) 0.76

Reasons for prescribing second generation antihistamines to treat allergic rhinitis in real-life conditions and patient response. Allergy Asthma Clin Immunol (2014) 0.76

Role of bilastine in the management of allergic rhinitis and urticaria: an Asia-Pacific consensus statement. Asia Pac Allergy (2016) 0.76

Diseases of the nose and paranasal sinuses in child. GMS Curr Top Otorhinolaryngol Head Neck Surg (2014) 0.76

Seasonal allergic rhinitis: fluticasone propionate and fluticasone furoate therapy evaluated. J Asthma Allergy (2010) 0.76

Efficacy of mometasone furoate and fluticasone furoate on persistent allergic rhinoconjunctivitis. Allergy Rhinol (Providence) (2013) 0.76

Knockdown of neurokinin-1 receptor expression by small interfering RNA prevents the development of allergic rhinitis in rats. Inflamm Res (2013) 0.75

Reliability assessment of the endoscopic examination in patients with allergic rhinitis. Allergy Rhinol (Providence) (2016) 0.75

Factors Associated with the Use of Different Treatment Modalities among Patients with Upper Airway Diseases in Taiwan: A Cross-Sectional Survey Study. J Allergy (Cairo) (2013) 0.75

360 degree perspective on allergic rhinitis management in Italy: a survey of GPs, pharmacists and patients. Clin Mol Allergy (2015) 0.75

Nasal breathing exercise and its effect on symptoms of allergic rhinitis. Indian J Otolaryngol Head Neck Surg (2011) 0.75

A common language to assess allergic rhinitis control: results from a survey conducted during EAACI 2013 Congress. Clin Transl Allergy (2015) 0.75

Evaluation of patients' expectations and benefits in the treatment of allergic rhinitis with a new tool: the patient benefit index - the benefica study. Allergy Asthma Clin Immunol (2015) 0.75

Effects of add-on montelukast on airway hyperresponsiveness in patients with well-controlled asthma - a pilot study. J Drug Assess (2013) 0.75

Authorised allergen products for intracutaneous testing may no longer be available in Germany: Allergy textbooks have to be re-written. Allergo J Int (2015) 0.75

Efficacy of fluticasone furoate nasal spray and levocetirizine in patients with Japanese cedar pollinosis subjected to an artificial exposure chamber. J Drug Assess (2013) 0.75

Managing co-morbid asthma with allergic rhinitis: targeting the one-airway with leukotriene receptor antagonists. World Allergy Organ J (2012) 0.75

Study of nasal exhaled nitric oxide levels in diagnosis of allergic rhinitis in subjects with and without asthma. J Asthma Allergy (2017) 0.75

Peripheral erythrocytes decrease upon specific respiratory challenge with grass pollen allergen in sensitized mice and in human subjects. PLoS One (2014) 0.75

Multi-morbidities of allergic rhinitis in adults: European Academy of Allergy and Clinical Immunology Task Force Report. Clin Transl Allergy (2017) 0.75

Concomitant corticosteroid nasal spray plus antihistamine (oral or local spray) for the symptomatic management of allergic rhinitis. Eur Arch Otorhinolaryngol (2015) 0.75

Chinese Herbal Medicine to Treat Allergic Rhinitis: Evidence From a Meta-Analysis. Allergy Asthma Immunol Res (2018) 0.75

Articles by these authors

Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy (2008) 12.35

Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J (2008) 10.08

A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy (2001) 5.07

Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE. Allergy (2005) 3.22

Induction of nitric oxide synthase in asthma. Lancet (1994) 2.93

Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. Am Rev Respir Dis (1992) 2.89

Standards for practical allergen-specific immunotherapy. Allergy (2006) 2.70

Practical guide to skin prick tests in allergy to aeroallergens. Allergy (2011) 2.51

Transforming growth factor-beta expression in mucosal biopsies in asthma and chronic bronchitis. Am J Respir Crit Care Med (1997) 2.47

Glucocorticoid receptor alpha and beta in glucocorticoid dependent asthma. Am J Respir Crit Care Med (2000) 2.36

Sputum metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio correlates with airflow obstruction in asthma and chronic bronchitis. Am J Respir Crit Care Med (1998) 2.36

Unmet clinical needs in chronic spontaneous urticaria. A GA²LEN task force report. Allergy (2010) 2.34

Phylogeny of nitrogenase sequences in Frankia and other nitrogen-fixing microorganisms. J Mol Evol (1989) 2.33

Cost-effectiveness of omalizumab in patients with severe persistent allergic asthma. Allergy (2007) 2.22

Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. J Allergy Clin Immunol (2012) 2.17

Chronic rhinosinusitis in Europe--an underestimated disease. A GA²LEN study. Allergy (2011) 2.13

Adverse effects of salmeterol in asthma: a neuronal perspective. Thorax (2009) 2.12

Quality of life in allergic rhinitis and asthma. A population-based study of young adults. Am J Respir Crit Care Med (2000) 2.08

EAACI position paper on rhinosinusitis and nasal polyps executive summary. Allergy (2005) 2.07

Pro: Immunotherapy is clinically indicated in the management of allergic asthma. Am J Respir Crit Care Med (2001) 2.04

T cell subsets and their soluble products regulate eosinophilia in allergic and nonallergic asthma. J Immunol (1991) 1.98

Grading quality of evidence and strength of recommendations in clinical practice guidelines. Part 1 of 3. An overview of the GRADE approach and grading quality of evidence about interventions. Allergy (2009) 1.97

Eosinophilic and neutrophilic inflammation in asthma, chronic bronchitis, and chronic obstructive pulmonary disease. J Allergy Clin Immunol (1993) 1.91

Corticosteroid reversibility in COPD is related to features of asthma. Am J Respir Crit Care Med (1997) 1.87

Efficacy and safety of a recombinant anti-immunoglobulin E antibody (omalizumab) in severe allergic asthma. Clin Exp Allergy (2004) 1.84

Lung function and asthma control with beclomethasone and formoterol in a single inhaler. Respir Med (2008) 1.82

Chemokine-receptor expression on T cells in lung compartments of challenged asthmatic patients. Clin Exp Allergy (2005) 1.76

Airway dendritic cell phenotypes in inflammatory diseases of the human lung. Eur Respir J (2007) 1.76

Emergency treatment of allergic reactions to Hymenoptera stings. Clin Exp Allergy (1991) 1.76

Recommendations for standardization of clinical trials with Allergen Specific Immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce. Allergy (2007) 1.75

Genome screen for asthma and related phenotypes in the French EGEA study. Am J Respir Crit Care Med (2000) 1.75

GA(2)LEN skin test study I: GA(2)LEN harmonization of skin prick testing: novel sensitization patterns for inhalant allergens in Europe. Allergy (2009) 1.72

Rhinosinusitis in severe asthma. J Allergy Clin Immunol (2001) 1.72

Asthma in adults and its association with chronic rhinosinusitis: the GA2LEN survey in Europe. Allergy (2011) 1.71

Low dose sublingual therapy in patients with allergic rhinitis due to house dust mite. Clin Allergy (1986) 1.71

Airway remodelling assessed by sputum and high-resolution computed tomography in asthma and COPD. Eur Respir J (2004) 1.70

Allergen immunotherapy: therapeutic vaccines for allergic diseases. World Health Organization. American academy of Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol (1998) 1.70

Airway inflammation in mild intermittent and in persistent asthma. Am J Respir Crit Care Med (1998) 1.69

Evaluation of apoptosis of eosinophils, macrophages, and T lymphocytes in mucosal biopsy specimens of patients with asthma and chronic bronchitis. J Allergy Clin Immunol (1999) 1.68

Inhaler competence in asthma: common errors, barriers to use and recommended solutions. Respir Med (2012) 1.68

Measurement of the internal size of bronchi using high resolution computed tomography (HRCT) Eur Respir J (1994) 1.67

Chloroplast and nuclear gene sequences indicate late Pennsylvanian time for the last common ancestor of extant seed plants. Proc Natl Acad Sci U S A (1994) 1.66

Visual analog scales can assess the severity of rhinitis graded according to ARIA guidelines. Allergy (2007) 1.63

Cost-effectiveness of asthma control: an economic appraisal of the GOAL study. Allergy (2006) 1.62

Objective assessment of endoscopic sinus surgery in the management of chronic rhinosinusitis: an update. J Laryngol Otol (1994) 1.62

Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with concomitant allergic asthma and persistent allergic rhinitis: SOLAR. Allergy (2004) 1.61

Anti-immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti-inflammatory activity and clinical efficacy. Clin Exp Allergy (2005) 1.59

Molecular evolution of angiosperm mitochondrial introns and exons. Proc Natl Acad Sci U S A (1997) 1.56

Is bronchial hyperresponsiveness more frequent in women than in men? A population-based study. Am J Respir Crit Care Med (1997) 1.54

[Smoking habits, attitudes and knowledges of medical students of Medicine, Pharmacy and Odonto-Stomatology's Faculty of Dakar, Senegal]. Rev Mal Respir (2003) 1.54

Visual analogue scale in patients treated for allergic rhinitis: an observational prospective study in primary care: asthma and rhinitis. Clin Exp Allergy (2013) 1.54

Nuclear factor-kappaB activity is down-regulated in nasal polyps from aspirin-sensitive asthmatics. Allergy (2003) 1.53

Grading quality of evidence and strength of recommendations in clinical practice guidelines: Part 2 of 3. The GRADE approach to grading quality of evidence about diagnostic tests and strategies. Allergy (2009) 1.53

Increased release of matrix metalloproteinase-9 in bronchoalveolar lavage fluid and by alveolar macrophages of asthmatics. Am J Respir Cell Mol Biol (1997) 1.53

GA(2)LEN skin test study II: clinical relevance of inhalant allergen sensitizations in Europe. Allergy (2009) 1.51

Consensus statement on the treatment of allergic rhinitis. European Academy of Allergology and Clinical Immunology. Allergy (2000) 1.50

Perennial rhinitis: An independent risk factor for asthma in nonatopic subjects: results from the European Community Respiratory Health Survey. J Allergy Clin Immunol (1999) 1.50

Precision of skin prick and puncture tests with nine methods. J Allergy Clin Immunol (1991) 1.50

Perennial rhinitis in the under 4s: a difficult problem to treat safely and effectively? A comparison of intranasal fluticasone propionate and ketotifen in the treatment of 2-4-year-old children with perennial rhinitis. Pediatr Allergy Immunol (2004) 1.49

Life-threatening food allergy in a child treated with FK506. J Pediatr Gastroenterol Nutr (1997) 1.49

Chronic respiratory diseases in developing countries: the burden and strategies for prevention and management. Bull World Health Organ (2001) 1.48

Does interferon-gamma improve pulmonary function in idiopathic pulmonary fibrosis? Eur Respir J (2003) 1.47

Glue ear guidelines. Lancet (1993) 1.47

Viruses and bacteria in acute asthma exacerbations--a GA² LEN-DARE systematic review. Allergy (2010) 1.45

Epidemiology of cypress pollen allergy in Montpellier. J Investig Allergol Clin Immunol (2012) 1.45

Gene transfer to human rheumatoid synovial tissue engrafted in SCID mice. J Rheumatol (1997) 1.43

Risk of first-generation H(1)-antihistamines: a GA(2)LEN position paper. Allergy (2010) 1.42

Pathogenesis and treatment of myasthenia gravis. Br Med J (Clin Res Ed) (1981) 1.41

Comparison of cord blood immunoglobulin E concentrations and maternal allergy for the prediction of atopic diseases in infancy. J Allergy Clin Immunol (1980) 1.40

[On the translation of lobar and lobectomy into Spanish]. Arch Bronconeumol (2005) 1.40

Effect of nitrogen dioxide on synthesis of inflammatory cytokines expressed by human bronchial epithelial cells in vitro. Am J Respir Cell Mol Biol (1993) 1.39

CT of the paranasal sinuses and functional endoscopic surgery: a critical analysis of 100 symptomatic patients. J Laryngol Otol (1991) 1.39

Reproterol: beta-2-agonist, theophylline, or both? Respiration (1999) 1.39

[beta(2)-Sympathomimetics: risks for asthma therapy? Lessons from the SMART1 Study. A statement from the German Respiratory Tract League]. Dtsch Med Wochenschr (2007) 1.39

[Gastric site of epidermoid carcinoma]. Presse Med (1997) 1.39

[Application of the WHO chronic respiratory diseases programme in Sub-Saharian Africa: problems in Senegal]. Rev Mal Respir (2004) 1.39

[Non-communicable chronic diseases, a global public health priority recognized by the United Nations]. Presse Med (2011) 1.39

[Hematothorax after sudden chest pain]. Dtsch Med Wochenschr (2006) 1.38

Epidemiologic evidence for asthma and rhinitis comorbidity. J Allergy Clin Immunol (2000) 1.38

Common characteristics of upper and lower airways in rhinitis and asthma: ARIA update, in collaboration with GA(2)LEN. Allergy (2007) 1.35

Interleukin-9 potentiates the interleukin-4-induced immunoglobulin (IgG, IgM and IgE) production by normal human B lymphocytes. Eur J Immunol (1993) 1.35

The correlation between asthma control and health status: the GOAL study. Eur Respir J (2006) 1.33

Immunohistochemical characterization of the cellular infiltration in asthmatic bronchi. Am Rev Respir Dis (1992) 1.31

Sputum eosinophils from asthmatics express ICAM-1 and HLA-DR. Clin Exp Immunol (1991) 1.30

Hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs) - classification, diagnosis and management: review of the EAACI/ENDA(#) and GA2LEN/HANNA*. Allergy (2011) 1.30

Grading quality of evidence and strength of recommendations in clinical practice guidelines part 3 of 3. The GRADE approach to developing recommendations. Allergy (2011) 1.29

IL-4 induces functional cell-surface expression of CXCR4 on human T cells. J Immunol (1998) 1.28

GA² LEN/EAACI pocket guide for allergen-specific immunotherapy for allergic rhinitis and asthma. Allergy (2010) 1.28

Computed tomography of the lungs in asthma: influence of disease severity and etiology. Am J Respir Crit Care Med (1996) 1.28

Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children. J Allergy Clin Immunol (1997) 1.27

HLA-DR and ICAM-1 expression on bronchial epithelial cells in asthma and chronic bronchitis. Am Rev Respir Dis (1993) 1.26

Chest radiography and high resolution computed tomography of the lungs in asthma. Am Rev Respir Dis (1992) 1.26

The purinergic receptor P2Y2 receptor mediates chemotaxis of dendritic cells and eosinophils in allergic lung inflammation. Allergy (2010) 1.26

Is sensitization to Alternaria alternata a risk factor for severe asthma? A population-based study. J Allergy Clin Immunol (1999) 1.25

Asthma mortality in France. J Allergy Clin Immunol (1987) 1.25

Standard skin prick testing and sensitization to inhalant allergens across Europe--a survey from the GALEN network. Allergy (2005) 1.25